Global Viral Clearance Market Report and Forecast 2023-2031

Global Viral Clearance Market Report and Forecast 2023-2031


Global Viral Clearance Market Outlook:


The global viral clearance market value was USD 521.8 million in 2022, driven by the need to eliminate viral contaminants and reduce the risk of transmission through therapeutic products. The market size is anticipated to grow at a CAGR of 17% during the forecast period of 2023-2031 to achieve a value of USD 2170.3 million by 2031.

Introduction

Viral clearance is a critical process in the development and manufacturing of biopharmaceutical products, ensuring the removal or inactivation of viral contaminants to safeguard patient safety. It involves a series of steps and measures taken to detect, quantify, and eliminate viruses from biological materials used in the production of biologics, vaccines, and other therapeutic products.

Key Trends in the Viral Clearance Market


Some of the key trends in the market are:

Increasing Stringency in Regulatory Requirements: Regulatory authorities are continuously raising the bar for viral clearance in biopharmaceutical products. There is a growing emphasis on comprehensive and robust viral clearance studies to mitigate the risk of viral contamination. This trend is driven by the need to ensure the safety of patients and prevent the transmission of viral infections through therapeutic products.
Advancements in Viral Clearance Technologies: The field of viral clearance is witnessing continuous advancements in technologies and methods used for viral detection and elimination. Newer and more efficient viral clearance techniques, such as virus filtration, chromatography, and viral inactivation methods, are being developed to enhance the effectiveness and reliability of the process. These advancements help in improving the overall viral clearance efficiency and reducing the risk of viral contamination.
Focus on Viral Safety in Novel Therapeutic Approaches: With the emergence of novel therapeutic approaches, such as gene therapies and cell-based therapies, there is a heightened focus on ensuring viral safety in these innovative treatment modalities. These therapies involve the use of viral vectors or genetically modified cells, making viral clearance an essential step in the manufacturing process. The development of viral clearance strategies specific to these advanced therapies is a key trend in the field.
Adoption of Disposable Technologies: The use of disposable technologies in viral clearance processes is gaining popularity. Disposable filters, chromatography columns, and other single-use components offer advantages such as ease of use, reduced risk of cross-contamination, and improved process efficiency. The adoption of disposable technologies simplifies process validation and scale-up, making viral clearance more cost-effective and streamlined.
Increasing Outsourcing of Viral Clearance Services: Pharmaceutical companies are increasingly outsourcing viral clearance studies and services to specialized contract research organizations (CROs) and testing laboratories. This trend is driven by the need for expertise, infrastructure, and specialized equipment required for comprehensive viral clearance studies. Outsourcing allows companies to leverage the knowledge and capabilities of experienced service providers, enabling them to focus on core activities and accelerate the development of their biopharmaceutical products.

Viral Clearance Market Segmentations


Market Breakup by Method

Viral Removal Method
Viral Inactivation Method
Other Methods
Market Breakup by Application

Recombinant Proteins
Vaccines
Blood and Blood Products
Cellular and Gene Therapy Products
Others
Market Breakup by End User

Contract Research Organization (CRO)
Pharmaceutical and Biotech Industry
Academic Research Institutes
Others
Market Breakup by Region

North America
United States of America
Canada
Europe
United Kingdom
Germany
France
Italy
Others
Asia Pacific
China
Japan
India
ASEAN
Australia
Others
Latin America
Brazil
Argentina
Mexico
Others
Middle East and Africa
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Others

Viral Clearance Market Scenario


The market for viral clearance services and technologies plays a vital role in ensuring the safety and quality of biopharmaceutical products. As regulatory requirements become more stringent and novel therapies emerge, the demand for effective viral clearance solutions continues to grow.

The market for viral clearance is driven by the need to eliminate viral contaminants and reduce the risk of transmission through therapeutic products. Biopharmaceutical companies invest in viral clearance services and technologies to comply with regulatory guidelines and ensure patient safety. This includes conducting comprehensive viral clearance studies, employing advanced viral detection and elimination techniques, and implementing robust quality control measures throughout the manufacturing process.

The market is characterized by continuous advancements in viral clearance technologies. Innovative solutions such as advanced filtration methods, chromatography techniques, and viral inactivation approaches are being developed to enhance the efficiency and reliability of the viral clearance process. These technologies aim to provide better viral removal or inactivation, reduce process cycle times, and improve overall product yields.

Another significant trend in the market is the increasing adoption of disposable technologies. Disposable filters, chromatography columns, and other single-use components offer advantages such as cost-effectiveness, convenience, and reduced risk of cross-contamination. These disposable technologies simplify process validation, scale-up, and mitigate the need for complex cleaning and sterilization procedures, thereby improving operational efficiency.

Furthermore, the market is witnessing a rise in outsourcing of viral clearance services. Biopharmaceutical companies are partnering with specialized contract research organizations (CROs) and testing laboratories to leverage their expertise and state-of-the-art facilities. Outsourcing viral clearance studies allows companies to access specialized knowledge and resources, reduce costs, and accelerate product development timelines.

Viral Clearance Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

Merck KGaA
WuXi AppTec Co., Ltd
Charles River Laboratories International, Inc.
Texcell SA
Vironova AB
Sartorius AG
Syngene International Limited
Creative Biogene
Eurofins Scientific
ALLURE MEDICAL GROUP
MARAVAI LIFESCIENCES HOLDINGS, INC.
ViruSure GmbH


1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Viral Clearance Market Analysis
8.1 Key Industry Highlights
8.2 Global Viral Clearance Historical Market (2018-2022)
8.3 Global Viral Clearance Market Forecast (2023-2028)
8.4 Global Viral Clearance Market by Method
8.4.1 Viral Removal Method
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Viral Inactivation Method
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.5 Global Viral Clearance Market by Application
8.5.1 Recombinant Proteins
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Vaccines
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Blood and Blood Products
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Cellular and Gene Therapy Products
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2022)
8.5.4.3 Forecast Trend (2023-2028)
8.5.5 Others
8.6 Global Viral Clearance Market by End Use
8.6.1 Contract Research Organisation (CRO)
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Pharmaceutical and Biotech Industry
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Academic Research Institutes
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Others
8.7 Global Viral Clearance Market by Region
8.7.1 North America
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Europe
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Asia Pacific
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Latin America
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2018-2022)
8.7.4.3 Forecast Trend (2023-2028)
8.7.5 Middle East and Africa
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2018-2022)
8.7.5.3 Forecast Trend (2023-2028)
9 North America Viral Clearance Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Viral Clearance Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Viral Clearance Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Viral Clearance Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Viral Clearance Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Merck KGaA
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 WuXi AppTec Co., Ltd
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Charles River Laboratories International, Inc.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Texcell SA
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Vironova AB
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Sartorius AG
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Syngene International Limited
15.2.7.1 Company Overview
15.2.7.2 Product Portfolio
15.2.7.3 Demographic Reach and Achievements
15.2.7.4 Certifications
15.2.8 Creative Biogene
15.2.8.1 Company Overview
15.2.8.2 Product Portfolio
15.2.8.3 Demographic Reach and Achievements
15.2.8.4 Certifications
15.2.9 Eurofins Scientific
15.2.9.1 Company Overview
15.2.9.2 Product Portfolio
15.2.9.3 Demographic Reach and Achievements
15.2.9.4 Certifications
15.2.10 Others
16 Key Trends and Developments in the Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings